NeuroOne Medical Technologies Reports Preliminary Q4 Sales ~$3.8M , Up 38.4% YoY; Sees FY26 Sales Of ~$10.5M, Up 15.6% YoY; Includes September Purchase Order Of $4.5M

NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) reported preliminary Q4 fiscal 2026 sales of approximately $3.8 million, a 38.4% increase year-over-year. For the full fiscal year 2026, the company anticipates revenue of around $10.5 million, reflecting a 15.6% growth and aligning with its prior guidance. Notably, in September 2026, NeuroOne secured a record $4.5 million purchase order, contributing to a total of $5.4 million in open purchase orders for the first quarter of fiscal 2027.